- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02516020
Effectiveness of Single Step Culture Media and Sequential Culture Media on Blastulation Rate
Effectiveness of Single Step Culture Media and Sequential Culture Media on Blastulation Rate: a Randomized Controlled Trial.
Study Overview
Detailed Description
Sequential culture media are designed to mimic the changing environment in the ovary ducts and the uterus in vivo. However, there are some differences between in vivo and in vitro culture conditions. Hence, single step media are created which allow the embryo itself to choose the necessary nutrients while maintaining a more stable culture environment. Previous studies suggest higher blastulation rate in the single step media than the sequential media.
This is an Randomized controlled trial (RCT) study comparing the blastulation rate of single step culture media and sequential culture media. Stimulation protocol is antagonist. Patient will be consulted on the day of ultrasound if they meet the inclusion criteria and sign the consent form. Then, the nurse will open the letter containing the type of media for that case. The media is prepared inside the lab a day before oocyte pick-up.
After oocyte pick-up, the oocyte-cumulus complex (OCC) will be cultured for 2 hours at 37°C, 6% Carbon dioxide (CO2) and 5% oxygen (O2). Meanwhile, sperm preparation will be performed using gradient technique. After 2 hours, OCC will be denuded and will be cultured for 1 hour until Intracytoplasmic Sperm Injection (ICSI). Oocytes after ICSI will be cultured in groups of 3-4 oocytes in the same conditions of 37 ° C, 6% CO2 and 5% O2. Fertilization check procedure is at 16-18 hours after ICSI. On day 3, the embryos will be evaluated in 66-68 hours after ICSI, grade 1 embryos are identified with 7-9 blastomeres and fragmentation is from 0-10%. The patients will be informed about the embryo quality. If the embryos are not decided to have day 5 transferring, patient will be consulted to transfer on day 3. Blastulation rate will not be recorded.
For the sequential culture media group, embryos will be transferred to Sequential Blast medium. For the single step culture media group, embryos will be transferred to the new culture dish with the same medium. On day 5, embryo quality assessment will be at 116±1 hours after ICSI. Blastocyst grading is based on the expansion, inner cell mass quality, and trophectoderm quality. Two good blastocyst will be transferred. After 11 days, beta-human chorionic gonadotropin (hCG) test will be required. If the beta-hCG result is positive, examination will be needed after 3 weeks and the luteal support will be given until 7 weeks.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ho Chi Minh, Vietnam
- My Duc Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Number of previous failure IVF cycles ≤2
- Using Gonadotropin-releasing hormone (GnRH) - Antagonist protocol for IVF
- Using GnRH for oocyte triggering.
- Read and sign consent form to participate in the study and have not been recruited for any other researches.
Exclusion Criteria:
- Oocyte donation cycles
- Abnormal uterine.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Global
EmbryoSingle step culture medium Embryos are cultured in single step culture from day 1 to day 5 Other Name: Global medium (LifeGlobal)
|
Embryos are cultured in single step culture from day 1 to day 5
Other Names:
|
|
Active Comparator: Origio
Sequential media Embryos are cultured in sequential medium from Day1 to Day 3 and from Day 3 to Day 5 (Sequential Blast) Other Name: Sequential Blast (Origio)
|
Embryos are cultured in sequential medium from Day1 to Day 3 and from Day 3 to Day 5 (Sequential Blast)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The blastulation rate
Time Frame: 116 ±1 hours after ICSI
|
The blastulation rate is defined as the number of blastocysts from 2 pronuclei (2PN) zygotes
|
116 ±1 hours after ICSI
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implantation rate
Time Frame: 11 days after embryo transfer
|
Implantation rate is defined as the number of gestational sacs per number of embryos transferred.
|
11 days after embryo transfer
|
|
Clinical pregnancy
Time Frame: 7 weeks after embryo transfer
|
Clinical pregnancy is defined by the image gestational sac under ultrasonography.
|
7 weeks after embryo transfer
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Tuong M Ho, MD, Research Center for Genetics and Reproductive Health
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCKH/CGRH_ 05_2015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Viable BiosciencesEnrolling by invitationInfertility (IVF Patients) | Infertility Assisted Reproductive TechnologyUnited States
Clinical Trials on Global
-
Association of Future African Neurosurgeons, Yaounde...Completed
-
EugoniaCompleted
-
DePuy OrthopaedicsTerminatedOsteoarthritis | Post Traumatic ArthritisUnited Kingdom, Netherlands, Canada, Germany
-
University of Rome Tor VergataCompletedCovid-19 | Surgery | COVID | Preventive Measures | Asymptomatic PatientItaly
-
Assistance Publique - Hôpitaux de ParisRecruitingProsthetic Joint Infection | Osteoarticular Infections | Intensive Care PatientsFrance
-
Hospices Civils de LyonRecruitingSickle Cell Disease (SCD)France
-
Mayo ClinicTerminatedDeep Vein ThrombosisUnited States
-
Herlev and Gentofte HospitalZealand University Hospital; DePuy SynthesUnknownProximal Humeral Fracture | Osteoarthritis of the ShoulderDenmark
-
University of ValenciaCompleted
-
Moens MaartenUnknown